GRIFOLS S.A. (GRF.MC) Financials
GRF.MC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 22.1 billion | 13.5 billion |
2023-06-30 | 21.4 billion | 13.2 billion |
2023-03-31 | 21.4 billion | 15.5 billion |
2022-12-31 | 21.5 billion | 13.1 billion |
GRF.MC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | ? | ? |
2023-06-30 | ? | ? |
2023-03-31 | ? | ? |
2022-12-31 | ? | ? |
GRF.MC Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-09-30 | 59.5 million |
2023-06-30 | 52.0 million |
2023-03-31 | -108.3 million |
2022-12-31 | 32.3 million |
GRF.MC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 543.6 million | - | - |
2023-06-30 | 557.2 million | 9.4 billion | - |
2023-03-31 | 464.0 million | 10.0 billion | - |
2022-12-31 | 578.6 million | - | 1.0 billion |
GRF.MC Shares Outstanding
GRF.MC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 88.4 million | 300.3 million | - |
2023-06-30 | 126.1 million | 87.3 million | 292.1 million | - |
2023-03-31 | 63.5 million | - | 413.7 million | - |
2022-12-31 | 76.8 million | 106.2 million | 329.7 million | - |
GRF.MC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.6 billion | 965.6 million |
2023-06-30 | 1.7 billion | 1.0 billion |
2023-03-31 | 1.6 billion | 1.0 billion |
2022-12-31 | 1.7 billion | 1.1 billion |
GRF.MC
Price: €8.65
52 week price:
Earnings Per Share: 0.09 EUR
P/E Ratio: 267.25
Exchange: MCE
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.1 million
Market Capitalization: 5.3 billion
Average Dividend Frequency: 2